The effects of an ACE inhibitor and a calcium antagonist on the progression of renal disease: the Nephros Study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The effects of an ACE inhibitor and a calcium antagonist on the progression of renal disease: the Nephros Study

Published:2001-11-01 Issue:11 Volume:16 Page:2158-2165
ISSN:1460-2385
Container-title:Nephrology Dialysis Transplantation
language:en
Short-container-title:

Author:

Herlitz Hans,Harris Kevin,Risler Teut,Boner Geoffrey,Bernheim Jacques,Chanard Jacques,Aurell Mattias

Publisher

Oxford University Press (OUP)

Subject

Transplantation,Nephrology

Link

http://academic.oup.com/ndt/article-pdf/16/11/2158/23368840/162158.pdf

Reference28 articles.

1. Brazy PC, Stead WW, Fitzwilliam JF. Progression of renal insufficiency: role of blood pressure. Kidney Int1989; 35: 670–674

2. National High Blood Pressure Education Program: National High Blood Pressure Education Program Working Group report on hypertension and chronic renal failure. Arch Intern Med1991; 151: 1280–1287

3. Anderson S, Rennke HG, Brenner BM. Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest1986: 77: 1993–2000

4. Björck S, Nyberg G, Mulec H, Granerus G, Herlitz H, Aurell M. Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropaty. Br Med J1986; 293: 471–474

5. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD, for the Collaborative Study Group. The effect of angiotensin‐converting‐enzyme inhibition on diabetic nephropathy. N Engl J Med1993; 329: 1456–1462

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adapting Clinical Practice Guidelines for Chronic Kidney Disease: Blood Pressure Management and Kidney Replacement Therapy in Adults and Children in the Saudi Arabian Context Using the Grading of Recommendations Assessment, Development, and Evaluation-ADOLOPMENT Methodology;Saudi Journal of Kidney Diseases and Transplantation;2023-12

2. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease;Cochrane Database of Systematic Reviews;2023-07-19

3. A Strategic Investigation on Diabetic Nephropathy; Its Conceptual Model and clinical Manifestations: A Review;Current Diabetes Reviews;2023-06

4. Clinical outcomes of renin angiotensin system inhibitor-based dual antihypertensive regimens in chronic kidney disease: a network meta-analysis;Scientific Reports;2023-04-07

5. SPECIFICITIES OF TREATMENT OF PATIENTS WITH CARDIOVASCULAR RISK IN COMORBIDITY;Актуальні проблеми сучасної медицини: Вісник Української медичної стоматологічної академії;2023-03-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3